UK investigates HIV/AIDS device cure claims
This article was originally published in Clinica
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued an alert concerning a probable scam involving claims that a medical device can cure HIV/AIDS, among other conditions. The ongoing police investigation is centred around a website under the name of Savec Health Systems, claiming that the device and associated medication has been used successfully in a number of Northern Ireland clinics and can be supplied to the public, subject to an online payment. "It would be extremely doubtful that any machine of this kind would have any value in the treatment of HIV/AIDS," said MHRA policy director Shaun Gallagher. "The evidence suggests that the product does not even exist and that this is simply a scam."
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.